Illumina Inc
(LTS:0J8Z)
$
107.5
-0.81 (-0.75%)
Market Cap: 17.29 Bil
Enterprise Value: 18.46 Bil
PE Ratio: 0
PB Ratio: 3.01
GF Score: 67/100 - Q1 2024 Illumina Inc Earnings Call TranscriptMay 02, 2024$124.48 (+0.91%)Earnings
- Q4 2023 Illumina Inc Earnings Call TranscriptFeb 08, 2024$143.15 (-0.41%)Earnings
- Illumina Inc at JPMorgan Healthcare Conference TranscriptJan 09, 2024
- Illumina Inc at Piper Sandler Healthcare Conference TranscriptNov 29, 2023
- Illumina Inc at Evercore ISI HealthCONx Conference TranscriptNov 28, 2023
- Q3 2023 Illumina Inc Earnings Call TranscriptNov 09, 2023$110.77Earnings
- Illumina Inc at Morgan Stanley Global Healthcare Conference TranscriptSep 11, 2023
- Illumina Inc at UBS Genomics 2.0 and MedTech Innovations Summit TranscriptAug 17, 2023
- Q2 2023 Illumina Inc Earnings Call TranscriptAug 09, 2023$186.63 (+1.60%)Earnings
- Illumina Inc To Host Third Annual Virtual ESG Investor Event TranscriptJun 12, 2023
- Q1 2023 Illumina Inc Earnings Call TranscriptApr 25, 2023$222.31 (-2.18%)Earnings
- Illumina Inc at Cowen Health Care Conference TranscriptMar 07, 2023
- Q4 2022 Illumina Inc Earnings Call TranscriptFeb 07, 2023$207.47 (-1.20%)Earnings
- Illumina Inc at JPMorgan Healthcare Conference TranscriptJan 09, 2023
- Illumina Inc at Piper Sandler Healthcare Conference TranscriptNov 30, 2022
- Illumina Inc at Evercore ISI HealthCONx Conference (Virtual) TranscriptNov 29, 2022
- Q3 2022 Illumina Inc Earnings Call TranscriptNov 03, 2022$211.83 (-1.81%)Earnings
- Illumina Inc To Host Second Annual Virtual ESG Investor Event TranscriptOct 28, 2022
- Illumina Inc 2022 Investor Day TranscriptOct 03, 2022
- Illumina Inc Innovation Roadmap Session - Corporate Call TranscriptSep 29, 2022
- Q2 2022 Illumina Inc Earnings Call TranscriptAug 11, 2022$231.37 (+2.84%)Earnings
- Illumina Inc at Bank of America Healthcare Conference TranscriptMay 12, 2022
- Q1 2022 Illumina Inc Earnings Call TranscriptMay 05, 2022$296.6 (-0.64%)Earnings
- Illumina Inc at Cowen Health Care Conference (Virtual) TranscriptMar 07, 2022
- Illumina Inc at Citi Healthcare Conference (Virtual) TranscriptFeb 24, 2022
- Illumina Inc at SVB Leerink Global Healthcare (Virtual) TranscriptFeb 17, 2022
- Q4 2021 Illumina Inc Earnings Call TranscriptFeb 10, 2022$363.84 (-1.27%)Earnings
- Illumina Inc at JPMorgan Healthcare Conference TranscriptJan 10, 2022
- Illumina Inc Inaugural ESG Investor Event TranscriptNov 16, 2021
- Q3 2021 Illumina Inc Earnings Call TranscriptNov 04, 2021$421.98 (+0.71%)Earnings
- Illumina Inc at Morgan Stanley Global Healthcare Conference (Virtual) TranscriptSep 13, 2021
- Illumina Inc Acquires Grail Inc Call TranscriptAug 18, 2021
- Illumina Inc at UBS Genomics 2.0 and MedTech Innovations Summit TranscriptAug 11, 2021
- Q2 2021 Illumina Inc Earnings Call TranscriptAug 05, 2021$509.69 (+1.41%)Earnings
- Illumina Inc at Goldman Sachs Global Healthcare Conference (Virtual) TranscriptJun 10, 2021
- Illumina Inc Annual Shareholders Meeting TranscriptMay 26, 2021
- Illumina Inc at Bank of America Global Research Healthcare Conference (Virtual) TranscriptMay 13, 2021
- Q1 2021 Illumina Inc Earnings Call TranscriptApr 27, 2021$417.19 (-0.41%)Earnings
- Illumina Inc at Cowen Healthcare Conference (Virtual) TranscriptMar 02, 2021
- Illumina Inc at SVB Leerink Global Healthcare Conference (Virtual) TranscriptFeb 25, 2021
- Q4 2020 Illumina Inc Earnings Call TranscriptFeb 11, 2021$454.04 (+0.29%)Earnings
- Illumina Inc at JPMorgan Healthcare Conference (Virtual) and Q&A Session TranscriptJan 11, 2021
- Illumina Inc at Piper Sandler Healthcare Conference (Virtual) TranscriptDec 03, 2020
- Q3 2020 Illumina Inc Earnings Call TranscriptOct 29, 2020$317.77 (+1.14%)Earnings
- Illumina Inc at Cowen Liquid Biopsy Summit (Virtual) TranscriptSep 24, 2020
- Illumina Inc to Acquire GRAIL - M&A Call TranscriptSep 21, 2020
- Illumina Inc at UBS Genomics 2.0 and Medtech Innovations Summit (Virtual) TranscriptAug 12, 2020
- Q2 2020 Illumina Inc Earnings Call TranscriptAug 06, 2020$399.57 (+0.49%)Earnings
- Illumina Inc Annual Shareholders Meeting TranscriptMay 27, 2020
- Q1 2020 Illumina Inc Earnings Call TranscriptApr 30, 2020$317.39 (-0.01%)Earnings
- Illumina Inc at Cowen HealthCare Conference TranscriptMar 03, 2020
- Illumina Inc at Leerink Global Healthcare Conference TranscriptFeb 26, 2020
- Q4 2019 Illumina Inc Earnings Call TranscriptJan 29, 2020$315.76Earnings
- Illumina Inc at JPMorgan Healthcare Conference - Presentation TranscriptJan 13, 2020
- Illumina Inc at Piper Jaffray Healthcare Conference TranscriptDec 05, 2019
- Illumina Inc at Evercore HealthCONx Conference TranscriptDec 04, 2019
- Q3 2019 Illumina Inc Earnings Call TranscriptOct 24, 2019$314.09 (+0.68%)Earnings
- Q2 2019 Illumina Inc Earnings Call TranscriptJul 29, 2019$302.41 (+1.52%)Earnings
- Illumina Inc at Goldman Sachs Global Healthcare Conference TranscriptJun 12, 2019
- Illumina Inc Annual Shareholders Meeting TranscriptMay 29, 2019
- Illumina Inc at Bank of America Merrill Lynch Health Care Conference TranscriptMay 15, 2019
- Q1 2019 Illumina Inc Earnings Call TranscriptApr 25, 2019$315.32 (-0.64%)Earnings
- Illumina Inc at Barclays Global Healthcare Conference TranscriptMar 13, 2019
- Q4 2018 Illumina Inc Earnings Call TranscriptJan 29, 2019$287.81Earnings
Illumina Inc at Piper Sandler Healthcare Conference Transcript
Nov 30, 2022 / 02:00PM GMT
Release Date Price:
$212.64
(+2.21%)
David Michael Westenberg
Piper Sandler & Co., Research Division - MD & Senior Research Analyst
All right. Thank you, everybody, for coming. Thank you, Illumina, for coming.
Questions & Answers
David Michael Westenberg
Piper Sandler & Co., Research Division - MD & Senior Research Analyst
I'm just going to start off with some of the weakness in the stock yesterday. Some of the things I heard from investors was -- number one, some of the 5% reduction in workforce, if that came before or after -- or you knew about that before or after when you gave long-range guidance or and even guidance for next year. And then number 2 is on the debt rate. So you've talked about some of the refi and some of the dynamics around the refinancing and kick it off that way.
Francis A. deSouza
Illumina, Inc. - CEO & Director
Yes. So look, our expectations on the long-range forecast that we gave or expectations that we gave have not changed, right? So we do expect that NGS and its ability to change how biology
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent ![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust_rating.png)
4.6 out of 5
Trustpilot
![](https://static.gurufocus.com/trust.png)